fludarabine

Known as: fludarabine [Chemical/Ingredient], 2-fluoroadenine arabinoside, 9-Beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine 
A fluorinated nucleotide antimetabolite analog of the antiviral agent vidarabine (ara-A) with antineoplastic activity. Administered parenterally as a… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
BACKGROUND On the basis of promising results that were reported in several phase 2 trials, we investigated whether the addition… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE Rituximab, a monoclonal antibody that targets the CD20 cell surface antigen, has clinical activity in patients with non… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Early results of the fludarabine, cyclophosphamide, and rituximab (FCR) regimen in 224 patients showed that it was highly active… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Fludarabine and cyclophosphamide (FC), which are active in treatment of chronic lymphocytic leukemia (CLL), are… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Combination chemotherapy with fludarabine plus cyclophosphamide (FC) was compared with the standard regimen of fludarabine… (More)
  • table 1
  • table 2
  • figure 1
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Recent studies have suggested that rituximab has clinical activity and modulates antiapoptotic proteins associated with drug… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
This study investigated the efficacy, safety, and clinical benefit of alemtuzumab (Campath-1H) for patients with relapsed or… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Fludarabine is an effective treatment for chronic lymphocytic leukemia that does not respond to initial treatment with… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE To investigate the use of a nonmyeloablative fludarabine-based preparative regimen to produce sufficient… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
I N 1988, THE National Cancer Institute-sponsored Working Group (NCI-WC) on chronic lymphocytic leukemia (CLL) published… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?